KLEIN, Christian,LANG, Sabine,POLSON, Andrew G.,UMANA, Pablo
申请号:
EPEP2014/058831
公开号:
WO2014/177617A1
申请日:
2014.04.30
申请国别(地区):
WO
年份:
2014
代理人:
摘要:
The present disclosure is directed to the combination therapy of an afucosylated anti-CD20 antibody with a CD22 antibody-drug conjugate for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Lyl antibody and a CD22 antibody-drug conjugate.La présente invention concerne la polythérapie dun anticorps anti-CD20 afucosylé avec un conjugué anticorps anti-CD22-médicament pour le traitement dun cancer, spécialement la polythérapie de cancers exprimant CD20 avec un anticorps B-Lyl afucosylé humanisé et un conjugué anticorps anti-CD22-médicament.